Your treating physician wants to authorize a lumbar fusion, the claims examiner refers it out, and eighteen days later a physician your client has never met, in a state he has never visited, denies it in three paragraphs that cite a guideline out of context. Every comp practitioner has lived some version of this. The question is not whether utilization review will frustrate you; it is whether you have built the record and watched the clock closely enough to turn the denial around. Getting treatment authorized is now a paperwork discipline as much as a medical one, and the attorneys who treat it that way win more of these fights.
How utilization review actually operates
Utilization review is the process by which a claims administrator decides whether to approve, modify, or deny requested medical treatment based on medical necessity. It runs in three modes, and the mode dictates the deadline. Prospective review addresses treatment not yet provided, the most common posture and the one with the tightest clock. Concurrent review covers ongoing or continuing care, such as a course of therapy already underway. Retrospective review addresses treatment already rendered, typically a billing dispute in disguise.
The timelines are strict and jurisdiction-specific, but the pattern is consistent: prospective and concurrent decisions must issue within a matter of a few business days of receipt of the request and supporting information, with an outer limit tied to receipt of the request itself. Expedited review, reserved for cases where the routine timeframe would seriously jeopardize the worker's health, compresses that to roughly a day. Retrospective decisions get a longer window measured in weeks. Missing any of these windows is not a harmless foot-fault. In many jurisdictions it is the whole case.
The timeliness defect and why it matters
Here is the leverage point most attorneys underuse. A utilization review decision that is untimely or otherwise procedurally defective is frequently treated as no valid decision at all. When that happens, the consequence in a number of jurisdictions is not that the dispute proceeds to independent medical review in the ordinary course. Instead, the timeliness or procedural defect returns the medical-necessity question to the appeals board, where you can litigate necessity on the merits before a judge rather than inside the closed IMR channel.
That distinction is worth real money, because the appeals board forum lets you put on your treating physician's opinion, cross-examine, and build a record. So calendar every request. Note the date the Request for Authorization was received, the date supporting records were received, and the date the decision issued and was communicated. If the decision landed outside the statutory window, or omitted a required element such as the reviewing physician's specialty rationale or a clear statement of the guideline relied upon, flag it immediately. Do not let a late or defective denial quietly funnel your client into the harder forum.
Building an RFA that survives review
The Request for Authorization is where cases are won before anyone denies anything. A bare RFA that says "authorize MRI" invites a denial for lack of supporting documentation. Attach the substantiation the reviewer needs to say yes, and frame it in the language the reviewer is bound to apply.
- Cite the applicable treatment guideline by name and section, and quote the specific indication your patient meets. Reviewers apply evidence-based-medicine standards and adopted guidelines; meet them on that ground rather than around it.
- Document the conservative care already tried and failed, with dates. Most surgical and interventional guidelines gate the requested procedure on a documented course of lesser treatment.
- Include objective findings that correlate with the request: imaging, exam findings, functional deficits, failed medication trials.
- Where the guideline is silent or the patient is an outlier, say so explicitly and supply the peer-reviewed literature supporting the departure. A reasoned, cited variance is far harder to deny than a bare request.
The point is to make denial require more work than approval. A reviewer with a defensible, guideline-anchored packet in front of them has a thin basis to modify or deny. This front-loading discipline overlaps heavily with the file-management habits that keep a whole caseload healthy, which is why strong firm intake and documentation practices pay off long before any authorization fight begins.
The IMR appeal and its narrow grounds
When utilization review denies or modifies treatment and the decision is timely and procedurally valid, the appeal in many systems runs to independent medical review rather than to a judge. IMR is a paper process. An anonymous reviewer assesses medical necessity against the same guidelines and the same record. Understand going in that IMR overturns a minority of denials, and that the grounds to challenge an IMR determination are deliberately narrow.
Once IMR issues, further appeal is limited to a short list of defects: fraud, a material conflict of interest, a reviewer acting outside the scope of practice, a mistake of fact not involving expert medical judgment, or a determination that exceeds statutory authority. Notably absent from that list is plain disagreement with the medical conclusion. You cannot appeal an IMR outcome simply because the reviewer weighed the evidence differently than your physician would. That structural reality means the real appellate work happens upstream, inside the RFA and the UR record, not after IMR has spoken.
Strategies for the hardest denials
Some categories draw reflexive denials, and they demand a tailored record.
Surgery
Surgical requests fail most often on the conservative-care gate and on missing correlation between imaging and symptoms. Build the timeline of failed non-operative treatment explicitly, and have the surgeon tie the objective findings to the functional loss and to the specific guideline indication. A second surgical opinion in the file, aligned with the request, adds weight.
Chronic pain and opioids
These are the denials where guidelines are least forgiving. For continued opioid therapy, the record must show function, not just pain scores: documented improvement in activity, a current treatment agreement, urine drug screening, morphine-equivalent dosing within range, and screening for aberrant behavior. A request that reports only that the patient still hurts will lose. A request that shows measurable functional benefit, monitored risk, and a taper plan where indicated gives the reviewer something to approve.
Making the treating physician's report carry
Ultimately the reviewer reads your physician's report, not your brief. So the report has to do the work. Push your treating doctors to write reports that state the diagnosis, recite the failed conservative care, cite the guideline and the indication met, explain any variance with literature, and connect the treatment to the industrial injury and to functional recovery. A conclusory report that asserts medical necessity without substantiation hands the reviewer a denial. A substantiated report, anchored in the standards the reviewer must apply, is the single best predictor of authorization.
The same rigor that gets treatment authorized also protects the value of the claim downstream, because unpaid and disputed treatment surfaces again at resolution. Keeping the medical record clean and the necessity documentation tight feeds directly into cleaner outcomes on lien and settlement resolution, and the whole discipline is core to modern workers' compensation practice. Treat authorization as a record-building exercise from the first RFA, and you spend far less time litigating denials that never had to happen.